Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. (Nasdaq: SNTI) is a synthetic biology company that went public through a business combination with Dynamics Special Purpose Corp., a life-sciences-focused blank-check vehicle that completed its initial public offering in 2021. Sponsored by Dynamics Research Group LLC, the SPAC targeted the biotechnology sector and entered into a definitive merger agreement with Senti Biosciences, a developer of programmable gene circuit medicines designed to address cancer and other serious diseases. The December 20, 2021 Form 8-K filing reflects a significant milestone in the de-SPAC process, bringing Senti's synthetic biology platform to public markets under the combined Senti Biosciences Holdings entity on Nasdaq. Sign up at SpacDesk for full sponsor profiles, filing histories, and deal analytics across the SPAC universe.